Afghanistan's narcotics problems grow worse

By R. Jeffrey Smith and Mattie Quinn

A costly and ambitious U.S. effort to curtail Afghanistan's poppy production falters as U.S. forces draw down.

OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "Pfizer":

"… ld, that translates into serious cash going into the pockets of investors. Pfizer’s most recently reported profit margin, for example, was 24.7 percent. A …"

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "New York":

"… public relations firm Hilltop Public Solutions, which has offices in D.C., New York and Billings, Mont.Little is known about the group, but Internal Revenue S …"

Panel recommends new agency to investigate safety of health information technology

By Kimberly Leonard

Institute of Medicine panel recommends new regulatory body, not FDA

Excerpts from this story referencing "National Transportation Safety Board":

"… create and fund a new independent watchdog agency, along the lines of the National Transportation Safety Board. Like NTSB, the new agency would conduct investigations and make recommend …"

Overmedicating young Louisiana inmates

By Matt Davis

Incarcerated youths in Louisiana are receiving powerful drugs even when their conditions don't call for it

Excerpts from this story referencing "Columbia":

"… associated with autism,” said Mark Olfson, a professor of psychiatry at Columbia University. “Antipsychotic treatment beyond these conditions raises conc …"

"… es down most heavily on youth with limited economic means. A 2009 study by Columbia and Rutgers universities showed that poor youth are four times more likely …"

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

Feds have done little to contain genetically modified animals and plants

By Laurel Adams

Government has done little to ensure genetically modified animals and plants don't escape into wild

Excerpts from this story referencing "Agriculture":

"… in, they could pose serious problems.Agencies under the U.S. Department of Agriculture are helping to finance this type of research, but its efforts to ensure ne …"

"… ns, or create regulations have fallen short.National Institute of Food and Agriculture has yet to create a formal process for documenting and monitoring research …"

"… animals.In 2008, the Advisory Committee on Biotechnology and 21st Century Agriculture, which provides advice to the Secretary of Agriculture on agricultural bio …"

"… gy and 21st Century Agriculture, which provides advice to the Secretary of Agriculture on agricultural biotechnology, expressed concerns that GE animals were bei …"

$1 billion for anti-narco programs, and no central database to track it

By Laurel Adams

State Department doesn't have a central tracking mechanism for its $1 billion counter-narcotics programs

Excerpts from this story referencing "Colombia":

"… ams.Most of State’s $1 billion supports programs in Mexico, Afghanistan, Colombia, Peru and Bolivia. The Bureau of International Narcotics and Law Enforceme …"

"… y have created a focus too narrow. The massive coca eradication program in Colombia, “Plan Colombia”, caused coca farmers to migrate to desolate jungle re …"

"… ocus too narrow. The massive coca eradication program in Colombia, “Plan Colombia”, caused coca farmers to migrate to desolate jungle regions on the Pacif …"

"… e UN Office on Drug and Crime measured 160,000 hectares of coca planted in Colombia, which produced 680 tons of cocaine. In 2007, after millions of hectares o …"

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "Delaware":

"… ugh, they say it’s difficult to know which is which.Sen. Tom Carper, the Delaware Democrat who requested the OIG investigation, was troubled by the results. …"

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from

Excerpts from this story referencing "Medicaid":

"… are Advantage plans are required to submit to the Centers for Medicare and Medicaid Services (CMS), the agency that administrators for the health insurance pl …"

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Excerpts from this story referencing "National Academy of Sciences":

"… out differences between men and women, according to a new report from the National Academy of Sciences.In the past, researchers concerned with how a study might damage a fetus o …"

"… -tech exporter and foreign companies obtaining 51 percent of U.S. patents (National Academy of Sciences)The number of subprime mortgages originated in 2000-07 that were seriously …"

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate

Excerpts from this story referencing "Delaware":

"… any combination to open the gate,” he said.Democratic Sen. Tom Carper of Delaware is demanding that the CMS set a time line of specific actions it will take …"

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

FDA asks hospitals to report safety glitches in digital health systems

By Fred Schulte and Emma Schwartz

In letter to 350 health centers, agency signals growing concern

FDA considers regulating safety of electronic health systems

By Fred Schulte and Emma Schwartz

Reports of patient harm include six deaths in two years

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

Major gaps in oversight of human medical research

By Jeanne Lenzer and Shannon Brownlee

Columbia Hospital case a cautionary tale

Government orders Columbia to tell patients 'true nature' of drug study

By Jeanne Lenzer and Shannon Brownlee

Officials say research may have caused harm to people who had heart surgery

ATF’s ‘ad hoc’ efforts give tobacco smugglers a free pass

By Te-Ping Chen

Smuggling cigarettes in America has become a multi-billion-dollar business, robbing states of desperately needed tax money and fueling organ

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Excerpts from this story referencing "Mexico":

"… om 637 sites in countries that include the United States, Canada, Ukraine, Mexico, Peru, and Colombia to take Celebrex, naproxen, or ibuprofen. Neither pati …"

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

Problems in oversight of food safety

By The Center for Public Integrity

Food safety oversight agencies often inconsistent and ineffective, says GAO

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

Excerpts from this story referencing "Merck":

"… manufacturer to act on its own. In September 2004 the pharmaceutical giant Merck voluntarily withdrew Vioxx after it became evident that the drug increased …"

The expert: watch an interview with Luk Joossens

By ICIJ

Watch an interview with Luk Joossens

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Excerpts from this story referencing "Prescription Drug User Fee Act":

"… try had better luck with two other laws it lobbied robustly to extend, the Prescription Drug User Fee Act and the Best Pharmaceuticals for Children Act. Both were reauthorized in t …"

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "Manufacturers of America":

"… h advocacy group.The drug industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA) spent more than $18 million on lobbying last year, more than any s …"

Pages